BIO.B - BIO-RAD LABORATORIES, INC.


234.41
9.120   3.891%

Share volume: 39
Last Updated: 04-21-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.05%

PREVIOUS CLOSE
CHG
CHG%

$225.29
9.12
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
45%
Profitability 33%
Dept financing 7%
Liquidity 75%
Performance 59%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
-3.13%
3 Months
-11.82%
6 Months
-11.82%
1 Year
-11.82%
2 Year
-11.82%
Key data
Stock price
$234.41
P/E Ratio 
0.00
DAY RANGE
$234.41 - $234.41
EPS 
-$25.93
52 WEEK RANGE
$225.29 - $265.82
52 WEEK CHANGE
-$11.82
MARKET CAP 
9.197 B
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$39
AVERAGE 30 VOLUME 
$19
Company detail
CEO: Norman D. Schwartz
Region: US
Website: bio-rad.com
Employees: 8,200
IPO year: 1980
Issue type:
Market: NYSE
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, sells, and markets a range of reagents, apparatus, and laboratory instruments. The clinical Diagnostics segment offers test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories.

Recent news
loading